These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 24706014)

  • 21. Insulin-like growth factor-1 and risk of late-onset Alzheimer's disease: findings from a family study.
    van Exel E; Eikelenboom P; Comijs H; Deeg DJ; Stek ML; Westendorp RG
    Neurobiol Aging; 2014 Mar; 35(3):725.e7-10. PubMed ID: 24054991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study.
    Schaefer EJ; Bongard V; Beiser AS; Lamon-Fava S; Robins SJ; Au R; Tucker KL; Kyle DJ; Wilson PW; Wolf PA
    Arch Neurol; 2006 Nov; 63(11):1545-50. PubMed ID: 17101822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study.
    Akomolafe A; Beiser A; Meigs JB; Au R; Green RC; Farrer LA; Wolf PA; Seshadri S
    Arch Neurol; 2006 Nov; 63(11):1551-5. PubMed ID: 17101823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study.
    McGrath ER; Himali JJ; Levy D; Conner SC; Pase MP; Abraham CR; Courchesne P; Satizabal CL; Vasan RS; Beiser AS; Seshadri S
    PLoS One; 2019; 14(3):e0213321. PubMed ID: 30830941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes.
    Pase MP; Beiser AS; Himali JJ; Satizabal CL; Aparicio HJ; DeCarli C; Chêne G; Dufouil C; Seshadri S
    JAMA Neurol; 2019 May; 76(5):598-606. PubMed ID: 30830207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Chronic Low-grade Inflammation With Risk of Alzheimer Disease in ApoE4 Carriers.
    Tao Q; Ang TFA; DeCarli C; Auerbach SH; Devine S; Stein TD; Zhang X; Massaro J; Au R; Qiu WQ
    JAMA Netw Open; 2018 Oct; 1(6):e183597. PubMed ID: 30646251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between serum insulin-like growth factor-1 levels and Alzheimer's disease and vascular dementia.
    Watanabe T; Miyazaki A; Katagiri T; Yamamoto H; Idei T; Iguchi T
    J Am Geriatr Soc; 2005 Oct; 53(10):1748-53. PubMed ID: 16181175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute exercise increases circulating IGF-1 in Alzheimer's disease patients, but not in older adults without dementia.
    Stein AM; da Silva TMV; Coelho FGM; Rueda AV; Camarini R; Galduróz RFS
    Behav Brain Res; 2021 Jan; 396():112903. PubMed ID: 32937170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Physical Function with Clinical and Subclinical Brain Disease: The Framingham Offspring Study.
    Camargo EC; Weinstein G; Beiser AS; Tan ZS; DeCarli C; Kelly-Hayes M; Kase C; Murabito JM; Seshadri S
    J Alzheimers Dis; 2016 Jul; 53(4):1597-608. PubMed ID: 27540965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people.
    den Heijer T; Geerlings MI; Hoebeek FE; Hofman A; Koudstaal PJ; Breteler MM
    Arch Gen Psychiatry; 2006 Jan; 63(1):57-62. PubMed ID: 16389197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating insulin-like growth factor-1 and brain health: Evidence from 369,711 participants in the UK Biobank.
    Cao Z; Min J; Tan Q; Si K; Yang H; Xu C
    Alzheimers Res Ther; 2023 Aug; 15(1):140. PubMed ID: 37608387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort study.
    Sundelöf J; Giedraitis V; Irizarry MC; Sundström J; Ingelsson E; Rönnemaa E; Arnlöv J; Gunnarsson MD; Hyman BT; Basun H; Ingelsson M; Lannfelt L; Kilander L
    Arch Neurol; 2008 Feb; 65(2):256-63. PubMed ID: 18268197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occupational exposure to pesticides increases the risk of incident AD: the Cache County study.
    Hayden KM; Norton MC; Darcey D; Ostbye T; Zandi PP; Breitner JC; Welsh-Bohmer KA;
    Neurology; 2010 May; 74(19):1524-30. PubMed ID: 20458069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
    Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
    Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study.
    Irie F; Fitzpatrick AL; Lopez OL; Kuller LH; Peila R; Newman AB; Launer LJ
    Arch Neurol; 2008 Jan; 65(1):89-93. PubMed ID: 18195144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Alzheimer's disease.
    Duron E; Funalot B; Brunel N; Coste J; Quinquis L; Viollet C; Belmin J; Jouanny P; Pasquier F; Treluyer JM; Epelbaum J; le Bouc Y; Hanon O
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4673-81. PubMed ID: 23015654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subjective Cognitive Decline Plus and Longitudinal Assessment and Risk for Cognitive Impairment.
    Kang M; Li C; Mahajan A; Spat-Lemus J; Durape S; Chen J; Gurnani AS; Devine S; Auerbach SH; Ang TFA; Sherva R; Qiu WQ; Lunetta KL; Au R; Farrer LA; Mez J
    JAMA Psychiatry; 2024 Oct; 81(10):993-1002. PubMed ID: 38959008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients.
    Sluimer JD; van der Flier WM; Karas GB; Fox NC; Scheltens P; Barkhof F; Vrenken H
    Radiology; 2008 Aug; 248(2):590-8. PubMed ID: 18574133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Revisiting the Role of Insulin-Like Growth Factor-I Receptor Stimulating Activity and the Apolipoprotein E in Alzheimer's Disease.
    Galle SA; van der Spek A; Drent ML; Brugts MP; Scherder EJA; Janssen JAMJL; Ikram MA; van Duijn CM
    Front Aging Neurosci; 2019; 11():20. PubMed ID: 30809143
    [No Abstract]   [Full Text] [Related]  

  • 40. Changes in Alzheimer Disease Blood Biomarkers and Associations With Incident All-Cause Dementia.
    Lu Y; Pike JR; Chen J; Walker KA; Sullivan KJ; Thyagarajan B; Mielke MM; Lutsey PL; Knopman D; Gottesman RF; Sharrett AR; Coresh J; Mosley TH; Palta P
    JAMA; 2024 Oct; 332(15):1258-1269. PubMed ID: 39068543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.